Breast Pre-Cancer Atlas Center

乳腺癌前期阿特拉斯中心

基本信息

  • 批准号:
    10819754
  • 负责人:
  • 金额:
    $ 13.37万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-04-04 至 2024-08-31
  • 项目状态:
    已结题

项目摘要

ABSTRACT Development of invasive breast cancer may frequently progress through a preinvasive precursor called ductal carcinoma in situ (DCIS). DCIS is a common clinical diagnosis that is essentially a disease of screening triggered by the detection of abnormal breast calcifications on mammography. Before the advent of mammography, DCIS was an incidental and relatively uncommon finding. Over 60,000 women in the United States will be presented with this diagnosis each year with relatively weak evidence-based guidance for disease management which ranges from active surveillance to bilateral mastectomy. We propose to compile multi-dimensional and multi-scale data on DCIS to construct a Pre-Cancer Atlas that can be used to better understand the disease but also to better stratify risk of progression. To do this, we have assembled a team of investigators with deep and complementary clinical, experimental, and quantitative expertise and experience with DCIS and breast cancer. Further, we conduct these studies with full consideration of tumor evolution and ecology as it pertains to precancer development and progression. Specific aspects of the proposed Atlas construction include: 1) Several types of DCIS cohorts that will capture spatial and longitudinal information including a prospective clinical trial cohort undergoing active surveillance, 2) Analyses designed to maintain relevant spatial organization of the disease for evolutionary and Atlas building considerations based on 3) Radiologic-histologic-cellular- molecular registration approaches, 4) Characterization at multiple scales including whole tumor, single duct and single cell levels, 5) Characterization of relevant parameters including mutations, copy number changes, methylation, gene expression, and microenvironmental elements including inflammatory cell profiles. 6) Incorporation of the breast cancer intrinsic subtype paradigm into the analytic phase, and 7) Layered, spatial, and longitudinal data visualization. Overall, this work will provide a comprehensive platform to guide the next generation of studies on DCIS and other precancers.
摘要 浸润性乳腺癌的发展可能经常通过一种称为 导管原位癌(DCIS)。DCIS是一种常见的临床诊断,本质上是一种疾病 在乳房X光检查中发现异常的乳房钙化而触发的筛查。在此之前 乳房X光检查的出现,DCIS是一个偶然且相对不常见的发现。超过6万名女性 在美国,每年都会出现这种诊断,证据相对薄弱 指导疾病管理,从积极监测到双侧乳房切除术。我们 建议汇编DCIS的多维和多尺度数据,以构建一份癌症前地图集,该地图集 可以用来更好地了解疾病,也可以更好地对进展风险进行分层。为了做到这一点,我们 已经组建了一支研究团队,具有深入和互补的临床、实验和 在DCIS和乳腺癌方面的量化专业知识和经验。此外,我们还进行了这些研究 充分考虑肿瘤的进化和生态学,因为它与癌症前发展和 进步。拟议的Atlas建设的具体方面包括:1)几种类型的DCIS 将捕获空间和纵向信息的队列,包括预期临床试验队列 正在进行主动监视,2)旨在保持相关空间组织的分析 基于放射学-组织学-细胞学的进化和图谱构建考虑的疾病 分子配准方法,4)包括整个肿瘤、单个肿瘤在内的多尺度表征 导管和单细胞水平,5)相关参数的表征,包括突变、拷贝数 改变、甲基化、基因表达和包括炎症细胞在内的微环境因素 配置文件。6)将乳腺癌固有亚型范式纳入分析阶段,以及7) 分层、空间和纵向数据可视化。总体而言,这项工作将提供全面的 指导下一代对DCIS和其他癌前病变的研究的平台。

项目成果

期刊论文数量(17)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Testing Adaptive Therapy Protocols using Gemcitabine and Capecitabine on a Mouse Model of Endocrine-Resistant Breast Cancer.
在内分泌耐药乳腺癌小鼠模型上使用吉西他滨和卡培他滨测试适应性治疗方案。
  • DOI:
    10.1101/2023.09.18.558136
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Seyedi,Sareh;Teo,Ruthanne;Foster,Luke;Saha,Daniel;Mina,Lida;Northfelt,Donald;Anderson,KarenS;Shibata,Darryl;Gatenby,Robert;Cisneros,Luis;Troan,Brigid;Anderson,AlexanderRA;Maley,CarloC
  • 通讯作者:
    Maley,CarloC
Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in situ: Analysis of TBCRC 038 and RAHBT cohorts.
  • DOI:
    10.1016/j.ccell.2022.10.021
  • 发表时间:
    2022-12-12
  • 期刊:
  • 影响因子:
    50.3
  • 作者:
    Strand, Siri H.;Rivero-Gutierrez, Belen;Houlahan, Kathleen E.;Seoane, Jose A.;King, Lorraine M.;Risom, Tyler;Simpson, Lunden A.;Vennam, Sujay;Khan, Aziz;Cisneros, Luis;Hardman, Timothy;Harmon, Bryan;Couch, Fergus;Gallagher, Kristalyn;Kilgore, Mark;Wei, Shi;DeMichele, Angela;King, Tari;McAuliffe, Priscilla F.;Nangia, Julie;Lee, Joanna;Tseng, Jennifer;Storniolo, Anna Maria;Thompson, Alastair M.;Gupta, Gaorav P.;Burns, Robyn;Veis, Deborah J.;DeSchryver, Katherine;Zhu, Chunfang;Matusiak, Magdalena;Wang, Jason;Zhu, Shirley X.;Tappenden, Jen;Ding, Daisy Yi;Zhang, Dadong;Luo, Jingqin;Jiang, Shu;Varma, Sushama;Anderson, Lauren;Straub, Cody;Srivastava, Sucheta;Curtis, Christina;Tibshirani, Rob;Angelo, Robert Michael;Hall, Allison;Owzar, Kouros;Polyak, Kornelia;Maley, Carlo;Marks, Jeffrey R.;Colditz, Graham A.;Hwang, E. Shelley;West, Robert B.
  • 通讯作者:
    West, Robert B.
Epigenome and early selection determine the tumour-immune evolutionary trajectory of colorectal cancer.
表观基因组和早期选择决定结直肠癌的肿瘤免疫进化轨迹。
  • DOI:
    10.1101/2024.02.12.579956
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Lakatos,Eszter;Gunasri,Vinaya;Zapata,Luis;Househam,Jacob;Heide,Timon;Trahearn,Nicholas;Swinyard,Ottilie;Cisneros,Luis;Lynn,Claire;Mossner,Maximilian;Kimberley,Chris;Spiteri,Inmaculada;Cresswell,GeorgeD;Llibre-Palomar,Gerard;Mi
  • 通讯作者:
    Mi
Testing Adaptive Therapy Protocols Using Gemcitabine and Capecitabine in a Preclinical Model of Endocrine-Resistant Breast Cancer.
  • DOI:
    10.3390/cancers16020257
  • 发表时间:
    2024-01-06
  • 期刊:
  • 影响因子:
    5.2
  • 作者:
    Seyedi, Sareh;Teo, Ruthanne;Foster, Luke;Saha, Daniel;Mina, Lida;Northfelt, Donald;Anderson, Karen S.;Shibata, Darryl;Gatenby, Robert;Cisneros, Luis H.;Troan, Brigid;Anderson, Alexander R. A.;Maley, Carlo C.
  • 通讯作者:
    Maley, Carlo C.
The Spatiotemporal Evolution of Lymph Node Spread in Early Breast Cancer.
  • DOI:
    10.1158/1078-0432.ccr-17-3374
  • 发表时间:
    2018-10-01
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Barry P;Vatsiou A;Spiteri I;Nichol D;Cresswell GD;Acar A;Trahearn N;Hrebien S;Garcia-Murillas I;Chkhaidze K;Ermini L;Huntingford IS;Cottom H;Zabaglo L;Koelble K;Khalique S;Rusby JE;Muscara F;Dowsett M;Maley CC;Natrajan R;Yuan Y;Schiavon G;Turner N;Sottoriva A
  • 通讯作者:
    Sottoriva A
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

E.Shelley Hwang其他文献

E.Shelley Hwang的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('E.Shelley Hwang', 18)}}的其他基金

Administrative Core
行政核心
  • 批准号:
    10900830
  • 财政年份:
    2023
  • 资助金额:
    $ 13.37万
  • 项目类别:
Extension to the HTAN Pre-Cancer Atlas Project
HTAN 癌前图谱项目的扩展
  • 批准号:
    10269615
  • 财政年份:
    2020
  • 资助金额:
    $ 13.37万
  • 项目类别:
Tissue Tension, RANK and Breast Cancer Risk
组织张力、RANK 和乳腺癌风险
  • 批准号:
    9918875
  • 财政年份:
    2018
  • 资助金额:
    $ 13.37万
  • 项目类别:
Breast Pre-Cancer Atlas Center
乳腺癌前期阿特拉斯中心
  • 批准号:
    10732796
  • 财政年份:
    2018
  • 资助金额:
    $ 13.37万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10732797
  • 财政年份:
    2018
  • 资助金额:
    $ 13.37万
  • 项目类别:
Biospecimen Acquisition, Processing and Classification Unit
生物样本采集、处理和分类装置
  • 批准号:
    9627376
  • 财政年份:
    2018
  • 资助金额:
    $ 13.37万
  • 项目类别:
Tissue Tension, RANK and Breast Cancer Risk
组织张力、RANK 和乳腺癌风险
  • 批准号:
    10328973
  • 财政年份:
    2018
  • 资助金额:
    $ 13.37万
  • 项目类别:
(PQC3) Genomic Diversity and Microenvironment as Drivers of Metastasis in DCIS
(PQC3) 基因组多样性和微环境作为 DCIS 转移的驱动因素
  • 批准号:
    8896592
  • 财政年份:
    2014
  • 资助金额:
    $ 13.37万
  • 项目类别:
(PQC3) Genomic Diversity and Microenvironment as Drivers of Metastasis in DCIS
(PQC3) 基因组多样性和微环境作为 DCIS 转移的驱动因素
  • 批准号:
    8687308
  • 财政年份:
    2014
  • 资助金额:
    $ 13.37万
  • 项目类别:
(PQC3) Genomic Diversity and Microenvironment as Drivers of Metastasis in DCIS
(PQC3) 基因组多样性和微环境作为 DCIS 转移的驱动因素
  • 批准号:
    9119786
  • 财政年份:
    2014
  • 资助金额:
    $ 13.37万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 13.37万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 13.37万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 13.37万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 13.37万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 13.37万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 13.37万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 13.37万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 13.37万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 13.37万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 13.37万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了